Karl Deisseroth

Karl Deisseroth (born 1971) is an American neuroscientist, psychiatrist, and bioengineer whose research develops and applies methods for investigating how specific cells and circuits contribute to brain function and behavior. He is the D. H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University and an investigator of the Howard Hughes Medical Institute. His career combines clinical psychiatry with experimental research on the biological mechanisms underlying behavior and psychiatric symptoms. (kyotoprize.org)

Deisseroth helped establish optogenetics, which combines genetically introduced light-sensitive proteins with optical stimulation to control the activity of selected cells. His collaborations encompass the development of microbial opsins as experimental tools, investigation of their molecular structures, and applications to neural circuits in behaving animals. His laboratory also developed CLARITY and related hydrogel-tissue chemistry methods, which enable three-dimensional examination of molecular and anatomical features within intact biological specimens. These approaches provide complementary means of manipulating neural activity and examining the organization of the brain. (laskerfoundation.org)

His work extends to circuit-level studies of motivation, perception, and dissociation, as well as scientific training and public communication. His book <i>Projections: A Story of Human Emotions</i> (2021) connects clinical narratives with neuroscience. On October 5, 2026, Deisseroth, Peter Hegemann, and Georg Nagel were announced as recipients of the 2026 Nobel Prize in Physiology or Medicine for discoveries concerning light-gated ion channels and optogenetics. (dlab.stanford.edu)

Early life and scientific education

Karl Deisseroth was born in Boston, Massachusetts, on November 18, 1971. His early academic interests included writing as well as science. In his autobiographical account for the 2018 Kyoto Prize lecture, he recalled entering Harvard University in the late 1980s with the intention of making writing his career, before becoming increasingly interested in developments in biology and engineering. His undergraduate education ultimately followed a scientific rather than a literary course. (web.stanford.edu)

At Harvard, Deisseroth studied biochemical sciences and graduated in 1992 with an A.B., awarded summa cum laude. His undergraduate record included a Harvard College Scholarship in 1989 and John Harvard Scholarships for academic achievement in 1990, 1991, and 1992. The biochemical sciences degree preceded his specialized training in neuroscience and medicine at Stanford University, where he entered the Medical Scientist Training Program in 1992. His curriculum vitae records his participation in that combined research and medical training program through 2000. (web.stanford.edu)

His Stanford research during this period examined how activity at the surface of a neuron could influence molecular processes in its nucleus. A paper published in Nature on March 12, 1998, with Deisseroth as first author and E. Kevin Heist and Richard W. Tsien as coauthors, investigated this connection in hippocampal neurons. The experiments showed that brief bursts of activity caused calmodulin, a calcium-binding protein, to move from the cytoplasm into the nucleus within approximately one minute. This movement supported rapid phosphorylation of CREB, a transcription factor associated with activity-dependent cellular responses. (nature.com)

The study also distinguished among routes of calcium entry: L-type calcium channels and NMDA receptors could mobilize calmodulin, whereas N-type and P/Q-type calcium channels did not produce the same response. This provided a specific example of how local signaling near the cell membrane could communicate with the nucleus. His training also included the course “Imaging Structure and Function in the Nervous System” at Cold Spring Harbor in 1995 and “Methods in Computational Neuroscience” at Woods Hole in 1997. (web.stanford.edu)

Deisseroth received his Ph.D. in neuroscience from Stanford in 1998 and his M.D. from the same university in 2000. These were separate degree milestones within his physician-scientist education: the neuroscience doctorate was awarded two years before completion of the medical degree. His subsequent medical internship and psychiatry residency continued at Stanford. (web.stanford.edu)

Academic career and clinical practice

Deisseroth joined the faculty of Stanford University in 2004 as an assistant professor and principal investigator in the departments of Bioengineering and Psychiatry and Behavioral Sciences. He held the assistant professorship until 2008, when he became an associate professor in both departments. In 2012 he was promoted to professor and appointed D. H. Chen Professor. These joint appointments placed his academic work across engineering and clinical psychiatry, rather than within a single neuroscience department. Stanford lists his professorial appointments in both departments, alongside membership in interdisciplinary programs including Bio-X and the Wu Tsai Neurosciences Institute. (kyotoprize.org)

His transition to the faculty followed postgraduate medical and research training at Stanford. After receiving his M.D. in 2000, he completed a medical internship in 2001 and an adult psychiatry residency in 2004. The Kyoto Prize biographical record describes the period from 2000 to 2004 as encompassing psychiatry residency and a postdoctoral fellowship. In 2006, two years after his faculty appointment, he obtained board certification in psychiatry from the American Board of Psychiatry and Neurology. The dates distinguish completion of supervised specialty training from the later professional certification; neither is interchangeable with the award of his medical degree. (profiles.stanford.edu)

In 2014 Deisseroth became an investigator of the Howard Hughes Medical Institute (HHMI), while retaining his Stanford position. HHMI describes his research program as developing tools to control and map defined components of intact biological systems, then combining those tools with optical, electrophysiological, computational, molecular, and behavioral methods. Its experimental work includes studies of neural physiology and behavior in freely moving mammals, with the aim of understanding circuit dynamics associated with both ordinary behavior and neuropsychiatric disease. The HHMI role is therefore a research appointment alongside his university posts, distinct from his clinical credential and patient-care responsibilities. (kyotoprize.org)

Deisseroth has also continued to practice psychiatry at Stanford. The university identifies his clinical specializations as affective disorders and autism-spectrum conditions, and describes his practice as employing medication and neural stimulation. These documented clinical activities are separate from laboratory experiments that manipulate or measure particular neural populations. His research addresses clinically relevant features—including depression, anxiety, and social dysfunction—but its circuit-level investigations should not be equated with treatments delivered in his psychiatric practice. The institutional accounts thus document two concurrent responsibilities: caring for patients as a board-certified psychiatrist and directing experimental investigations into the biological processes underlying behavior and psychiatric symptoms. (bioengineering.stanford.edu)

Establishment of microbial-opsin optogenetics

The molecular foundations of optogenetics preceded Deisseroth’s experiments in neurons by several decades. In 1971, Dieter Oesterhelt and Walther Stoeckenius reported that the purple membrane of the salt-loving archaeon then called Halobacterium halobium contained a retinal-bound protein, bacteriorhodopsin; subsequent experiments established its function as a light-driven proton pump. Peter Hegemann’s investigations of light responses in the green alga Chlamydomonas reinhardtii led to collaborations with Georg Nagel, Ernst Bamberg, and colleagues that characterized channelrhodopsin-1 in 2002 and channelrhodopsin-2 in 2003. Unlike a pump, channelrhodopsin provided a directly light-gated ion channel. The 2003 experiments demonstrated ChR2-mediated cation conductance in frog oocytes and mammalian cells, establishing a molecular capability distinct from its subsequent use to control neuronal firing. (nature.com)

Deisseroth’s contribution to this transition was documented in the paper “Millisecond-timescale, genetically targeted optical control of neural activity,” published online in Nature Neuroscience on August 14, 2005. Its authors, in order, were Edward S. Boyden, Feng Zhang, Ernst Bamberg, Georg Nagel, and Karl Deisseroth. The collaboration joined neuronal experiments at Stanford University with expertise in microbial photoreceptors from Bamberg and Nagel. Rather than discovering ChR2 itself, the researchers adapted it into an experimental system that combined genetically encoded light sensitivity, rapid illumination, and electrical measurement. The reported demonstration concerned cultured mammalian neurons, not behavioral control in an intact animal. (pubmed.ncbi.nlm.nih.gov)

The experimental system used lentiviral delivery to express ChR2 fused to a fluorescent marker in cultured hippocampal neurons. Blue-light pulses opened the introduced channels, producing inward currents and depolarization sufficient to trigger action potentials. Whole-cell patch-clamp recordings supplied the verification: voltage-clamp measurements detected light-evoked currents, while current-clamp measurements recorded changes in membrane potential and neuronal spikes. Brief pulses lasting 5, 10, or 15 milliseconds elicited temporally controlled firing. The study also demonstrated control of excitatory and inhibitory synaptic transmission: activating an inhibitory neuron could inhibit a downstream cell, although ChR2 itself excited the neuron expressing it. These measurements established control at the timescale of individual spikes and synaptic events rather than merely showing a cellular response to illumination. (web.stanford.edu)

Extension to the mammalian brain required both selective expression and a practical route for delivering light through tissue. In 2007, Alexander Aravanis, Li-Ping Wang, Zhang, and collaborators, including Deisseroth, reported an optical neural interface using a 473-nanometer laser coupled to a flexible optical fiber approximately 200 micrometers in diameter. A CaMKIIα promoter targeted ChR2 expression to excitatory neurons. Optical stimulation of rodent motor cortex produced whisker movements, linking the molecular intervention to measurable motor output. Importantly, no externally supplied retinal cofactor was required. Implanted fiber-guide interfaces allowed illumination to be aligned with the genetically modified neuronal population rather than relying on light applied only at the brain’s surface. (pubmed.ncbi.nlm.nih.gov)

Later in 2007, Antoine Adamantidis, Zhang, Aravanis, Deisseroth, and Luis de Lecea extended this approach to freely moving mice. They targeted ChR2 to hypocretin-producing neurons in the lateral hypothalamus and delivered light through an intracranial fiber. Stimulation with pulse trains at 5–30 hertz shortened the latency to awakening from both slow-wave and rapid-eye-movement sleep, whereas 1-hertz stimulation did not. This experiment tested whether activity in a genetically defined neuronal population could promote a behavioral-state transition, rather than merely correlate with it. Its authorship and technical dependencies illustrate the collaborative development of microbial-opsin optogenetics from photoreceptor discovery through cultured-cell validation to experiments in behaving mammals. (pubmed.ncbi.nlm.nih.gov)

Opsin mechanisms, structural biology, and tool engineering

Microbial opsins used in optogenetics are membrane proteins whose light sensitivity depends on a bound retinal molecule. Light absorption changes retinal’s configuration, initiating protein rearrangements that alter ion transport across the cell membrane. A light-gated ion channel opens a pathway through which ions move down their electrochemical gradients; a light-driven pump instead couples illumination to directional ion transport, potentially against a gradient. Channelrhodopsin-2 conducts positively charged ions and, under typical neuronal conditions, depolarizes the membrane potential, enabling action potentials. Halorhodopsin pumps chloride into cells, producing a hyperpolarizing current. These distinct mechanisms provided complementary means of increasing and suppressing neuronal activity. (pmc.ncbi.nlm.nih.gov)

In 2007, Feng Zhang, Li-Ping Wang, Martin Brauner, Deisseroth, and collaborators reported optical inhibition using halorhodopsin from the archaeon Natronomonas pharaonis, designated NpHR. Expressed in cultured hippocampal neurons, NpHR enabled millisecond-timescale suppression of firing under yellow illumination. Its excitation spectrum differed sufficiently from that of blue-light-sensitive channelrhodopsin-2 to permit bidirectional control in neurons expressing both proteins: one wavelength promoted firing, while another inhibited it. The collaboration also demonstrated opposing effects on locomotion in transgenic Caenorhabditis elegans. The inhibitory component was a chloride pump, not a chloride channel—a distinction important to understanding how illumination generated the current. (nature.com)

A structural collaboration published in January 2012 supplied an atomic framework for engineering channelrhodopsins. Hideaki E. Kato determined the structure of C1C2, a chimera combining channelrhodopsin-1 and channelrhodopsin-2 from Chlamydomonas reinhardtii, using X-ray crystallography at 2.3-ångström resolution. Osamu Nureki and Deisseroth jointly supervised the work, with contributions from Zhang, Ofer Yizhar, Peter Hegemann, and other collaborators. The structure resolved the retinal-binding pocket and identified a proposed cation-conduction pathway formed by transmembrane helices 1, 2, 3, and 7, including constrictions in the closed channel. Combined with electrophysiological analysis, it provided specific sites for testing how amino-acid substitutions affected conduction and gating, rather than relying solely on analogy with other microbial rhodopsins. (nature.com)

Wavelength engineering combined the search for naturally different opsins with the construction of chimeras and targeted mutations. In 2008, a collaboration involving Zhang, Hegemann, and Deisseroth characterized VChR1 from Volvox carteri, which could drive neuronal spikes with 589-nanometre light and had an excitation maximum approximately 70 nanometres red-shifted relative to channelrhodopsin-2. Subsequent work on C1V1 combined channelrhodopsin-1 and VChR1 sequences to improve expression while retaining longer-wavelength sensitivity. A 2012 study identified helices 6 and 7 as especially important for spectral differences between the Volvox channels, whereas helices 1 and 2 strongly affected expression. The C1V1 E122T substitution shifted the absorption maximum further, to approximately 545 nanometres, illustrating how spectral tuning and effective membrane expression required distinct molecular adjustments. (pubmed.ncbi.nlm.nih.gov)

Ion selectivity was another engineering target. In 2018, Yoon Seok Kim, Kato, Deisseroth, and collaborators reported the 2.9-ångström crystal structure of GtACR1, a naturally occurring anion-conducting channelrhodopsin from Guillardia theta. Unlike halorhodopsin, GtACR1 inhibits neuronal firing through a light-gated anion conductance rather than active chloride pumping. Structural comparisons with C1C2, together with electrophysiological and spectroscopic experiments, examined differences in the retinal-binding pocket, the protonated Schiff-base region that links retinal to the protein, and the ion-conduction pathway. These measurements connected molecular architecture with anion selectivity and supplied a framework for modifying inhibitory optical tools. (nature.com)

Circuit studies of motivation, social behavior, and perception

In 2014, Lisa A. Gunaydin, Logan Grosenick, Deisseroth, and colleagues published “Natural neural projection dynamics underlying social behavior,” examining dopamine-related circuitry in freely moving mice. They developed fiber photometry to collect fluorescence from genetically encoded calcium indicators through an implanted optical fiber, allowing population-level activity measurements from specified neurons and their axonal projections. Calcium signals served as an indirect activity readout, rather than a measurement of individual action potentials. In adult female mice, activity in the projection from the ventral tegmental area to the nucleus accumbens tracked and predicted features of interaction with another mouse, but not investigation of a novel object. Separate optogenetic experiments showed that manipulating neurons contributing to this projection could alter social interaction, with downstream D1 dopamine-receptor signaling implicated in the effect. Recording therefore addressed when a pathway was naturally engaged, whereas intervention tested whether changing its activity could influence behavior. (pmc.ncbi.nlm.nih.gov)

Kelly A. Zalocusky and colleagues, including Deisseroth, extended this approach to reward-based decision-making in a 2016 study of male Long–Evans rats. Animals chose between a “safe” lever delivering $50\,\mu\mathrm{l}$ of sucrose solution and a “risky” lever delivering $10\,\mu\mathrm{l}$ on 75% of trials or $170\,\mu\mathrm{l}$ on 25%; both options therefore had the same expected reward volume. Each session included 50 forced-choice trials followed by 200 free-choice trials. Photometry targeted accumbens cells expressing the D2 dopamine receptor. During the one-second nose-poke period preceding lever presentation, their activity was greater after an unfavorable risky outcome and before a subsequent safe choice. Larger loss-related signals were associated with greater risk aversion across animals. Optogenetic stimulation during this decision period reduced risky choices in risk-preferring rats. The study’s “loss” meant a reward smaller than the expected outcome, not the removal of an already possessed reward. (pmc.ncbi.nlm.nih.gov)

In 2019, William E. Allen, Liqun Luo, Deisseroth, and collaborators investigated how thirst changes the relationship between sensory input and motivated action. They recorded approximately 24,000 neurons across 34 brain regions in 87 sessions from 21 mice performing an olfactory Go/No-Go task as they consumed water and became sated. In thirsty animals, a water-predicting odor elicited activity that spread rapidly beyond olfactory regions, preceding licking and water acquisition. After satiation, the same cue still produced initial sensory responses, but the widespread task-related activity and behavioral response were greatly diminished. Population analyses distinguished activity associated with motivational state from activity associated with cues and behavior; state-related differences were present even before odor delivery. As a causal test, optogenetic activation of hypothalamic thirst-related neurons in sated mice reinstated task performance and shifted distributed neural activity toward the thirsty pattern. The experiment connected a localized physiological-need signal with changes across distributed sensory and action-related circuits. (pmc.ncbi.nlm.nih.gov)

A second 2019 study, by James H. Marshel, Yoon Seok Kim, Timothy A. Machado, Sean Quirin, Deisseroth, and colleagues, examined visual discrimination in mice. The researchers first identified neurons in primary visual cortex responsive to horizontal or vertical gratings, then combined calcium imaging with ChRmine-mediated, multiphoton holographic stimulation to activate selected ensembles. Stimulating sufficiently large groups of orientation-selective neurons recruited additional, functionally related cells and elicited the corresponding learned discrimination behavior even without the visual stimulus. Activity propagated preferentially from cortical layers 2/3 toward layer 5, and smaller layer-5 ensembles could produce behavioral effects comparable to larger superficial ensembles. These results linked specified cellular activity patterns to stimulus-specific behavioral reports and to population dynamics resembling those evoked by visual input. The measured endpoint was the mice’s trained discrimination response, not a direct account of subjective visual experience or a demonstration that their experience matched human perception. (pmc.ncbi.nlm.nih.gov)

Psychiatric research and dissociation

Deisseroth’s psychiatric research connects particular features of behavior and experience to defined cellular populations and patterns of neural activity, rather than treating an entire psychiatric diagnosis as a single experimentally manipulable entity. In his 2021 Lasker acceptance remarks, he described the laboratory’s aim as mapping individual features of adaptive and maladaptive brain states onto precisely specified circuit elements. This framework separates questions about the cells involved, their activity patterns, and the behavioral consequences of manipulating them. Anxiety and dissociation accordingly become subjects for component-level investigation, without assuming that one circuit accounts for every manifestation of a clinical disorder. (laskerfoundation.org)

A study published in Nature on September 16, 2020, led jointly by Sam Vesuna and Isaac V. Kauvar, with Deisseroth as senior author, investigated dissociation through mouse experiments and a separate human investigation. In the mouse behavioral assays, ketamine preserved reflexive paw-flicking on an uncomfortably warm surface while suppressing paw-licking, a more integrated protective response. The operational distinction was between responding to a sensory stimulus and producing additional stimulus-related behavior—not between conscious and unconscious animals. Because mice could not describe their experiences, these measurements were classified as dissociation-like behavior rather than direct evidence of subjective detachment. (med.stanford.edu)

Large-scale activity imaging identified a 1–3-hertz rhythm in layer 5 neurons of the retrosplenial cortex after ketamine or phencyclidine administration. Recordings with four simultaneous high-density probes showed coupling to connected thalamic circuitry but reduced coupling to much of the rest of the brain. To test causal involvement, the researchers used optogenetics to impose rhythmic activity on deep retrosplenial neurons; this reproduced dissociation-like behavioral effects without administering a dissociative drug. Local deletion of HCN1, a hyperpolarization-activated cyclic-nucleotide-gated ion channel, diminished ketamine-induced oscillations and restored paw-licking. These experiments tested both the behavioral consequences of imposing the rhythm and the requirement for local HCN1 channels in the ketamine response. (nature.com)

The human component involved one patient with focal epilepsy, not a psychiatric treatment cohort. Intracranial recordings detected a localized rhythm in deep posteromedial cortex associated with the patient’s self-reported dissociative aura before seizures. Brief electrical stimulation of that region also elicited dissociative experiences; Josef Parvizi performed the stimulation procedure. The human evidence therefore combined reported experience with recordings and an intervention, whereas the mouse evidence depended on observable behavioral proxies. Neither component tested whether suppressing the rhythm treated a dissociative disorder, established clinical efficacy, or demonstrated that the same mechanism explained dissociation across different diagnoses and circumstances. (nature.com)

CLARITY and hydrogel-tissue chemistry

On April 10, 2013, Nature published “Structural and molecular interrogation of intact biological systems,” introducing CLARITY as a method for examining molecular and anatomical features within intact tissue rather than reconstructing them from thin sections. Kwanghun Chung and Deisseroth conceived the experiments and wrote the paper; Chung led the technology’s development and implementation, while Deisseroth supervised the work. Collaborators included Jenelle Wallace, Sung-Yon Kim, Sandhiya Kalyanasundaram, Aaron Andalman, Thomas Davidson, and Viviana Gradinaru. Using mouse brains and human tissue specimens, the team sought to preserve the spatial relationships between fine cellular structures and larger anatomical systems while making those structures accessible to light and molecular probes. (nature.com)

CLARITY combines chemical stabilization with selective removal of tissue components. In the original method, tissue is infused with a solution containing formaldehyde, acrylamide, and a crosslinker; polymerization produces a water-rich hydrogel network interwoven with, and chemically linked to, retained biomolecules. This polymer framework supports proteins and other molecular structures while lipids, a major source of light scattering, are extracted with the detergent sodium dodecyl sulfate. An electric field accelerates removal of lipid-containing detergent micelles in the original electrophoretic procedure. Subsequent refractive-index matching further improves transparency. Lipid extraction also removes barriers to molecular access, allowing large probes to enter the porous tissue–hydrogel composite. In the original protein-retention assay, hydrogel-hybridized tissue lost approximately 8% of its protein during clearing, compared with approximately 65% in conventionally paraformaldehyde-fixed tissue exposed to the same 4% detergent solution. Preservation was therefore substantial but not complete. (pmc.ncbi.nlm.nih.gov)

The resulting preparations support complementary forms of labeling and three-dimensional microscopy. Retained fluorescent proteins reveal genetically labeled cells and their processes; fluorescent antibodies identify particular proteins; and in situ hybridization detects selected nucleic-acid sequences. The 2013 study demonstrated antibody labeling throughout an intact adult mouse brain and repeated staining and antibody removal in unsectioned tissue blocks. These procedures allow different molecular markers to be examined within the same anatomical framework, including long-range axons and local cellular relationships. CLARITY is nevertheless a method for analyzing chemically prepared tissue: its fluorescence images describe preserved structure and molecular composition, not ongoing electrical activity in a living brain. (nature.com)

A 2017 extension, “Pathways to clinical CLARITY,” addressed difficulties encountered with soft, irregular, and heterogeneous specimens. The collaboration included joint first authors Brian Hsueh and Vanessa M. Burns, together with Li Ye, Philip Pauerstein, Seung Kim, Deisseroth, and other researchers. Conventional embedding could cause fragile samples to clump, shear, or expand unevenly. The revised biphasic approach formed a solid hydrogel within the tissue while maintaining a liquid phase outside it and along irregular boundaries and cavities. Adjusting gel composition also improved clearing and antibody penetration; one formulation allowed homogeneous antibody staining of 1-millimeter-thick tissue blocks after 12 hours of incubation. (pmc.ncbi.nlm.nih.gov)

Pancreatic development provided a concrete application beyond the central nervous system. The researchers combined fluorescent lineage labeling, antibody staining, confocal imaging, and automated volumetric analysis to examine relationships between pancreatic islets and neural-crest-derived structures in developing mice. Human fetal pancreatic specimens, spanning 91–117 days after conception, were cleared for two to three weeks and labeled for insulin and neuronal β-tubulin; additional staining rounds revealed glucagon-expressing cells and vascular structures. The three-dimensional measurements captured islet volumes and fine innervation patterns that could be incompletely sampled or underestimated in conventional thin sections. (pmc.ncbi.nlm.nih.gov)

Spatial molecular mapping and integrated measurements

In 2018, Xiao Wang, William E. Allen, Karl Deisseroth, and collaborators introduced STARmap in the Science paper “Three-dimensional intact-tissue sequencing of single-cell transcriptional states.” The name abbreviates “spatially-resolved transcript amplicon readout mapping.” The method combines hydrogel-tissue chemistry, targeted nucleic-acid amplification, and in situ sequencing to measure gene expression while preserving cells’ three-dimensional positions. Its initial demonstrations mapped panels of 160–1,020 genes in mouse brain sections at single-cell resolution. Experiments in thicker, cubic-millimeter-scale tissue volumes encompassed more than 30,000 cells, revealing spatial gradients of excitatory-neuron subtypes and short-range clustering among several inhibitory-neuron subtypes. (rnajc.ucsf.edu)

STARmap uses paired probes that bind adjacent sequences on target RNA molecules, enabling local amplification of gene-identifying DNA barcodes. These amplified products are anchored within a polymer hydrogel and decoded through repeated sequencing and fluorescence-imaging cycles. Unlike tissue clearing alone, its principal readout is a spatially indexed molecular profile: which selected transcripts occur in a cell, and where that cell lies relative to neighboring cells and anatomical boundaries. The original implementation therefore measured a targeted gene panel rather than an unrestricted whole transcriptome, and examined prepared tissue rather than recording living neuronal activity. (rnajc.ucsf.edu)

A concrete integration of molecular mapping and functional measurement appeared in the 2022 Cell paper “Cell-type-specific population dynamics of diverse reward computations,” by Emily L. Sylwestrak, YoungJu Jo, Deisseroth, and colleagues. In mice, STARmap localized molecularly defined populations within the habenula, providing a basis for genetically targeted activity recordings. During a three-choice serial reaction-time task, animals nose-poked at a briefly illuminated port to obtain sucrose solution at a separate reward port. Fiber-photometry measurements and task variants that separated reward-predicting lights from reward delivery distinguished medial-habenular populations: TH-expressing cells preferentially signaled predictive cues, whereas Tac1-expressing cells carried information about reward outcomes and reward history. (pmc.ncbi.nlm.nih.gov)

The same study added single-cell calcium imaging and high-density electrical recordings with Neuropixels 2.0 probes; light-based identification of genetically targeted neurons linked recorded spikes to defined populations. Data-driven dynamical models described Tac1-population activity as consistent with a putative line attractor—a set of persistent population states potentially supporting reward-history integration. Electrophysiology and separate optogenetic perturbation experiments supplied supporting tests, rather than making the molecular map itself a demonstration of causal function. (escholarship.org)

Related recording developments supplied complementary temporal information. The 2014 study by Lisa A. Gunaydin and colleagues, including Deisseroth, developed and applied fiber photometry to monitor genetically encoded calcium-indicator fluorescence from specified neuronal populations and their projections in behaving mice. An implanted optical fiber delivers excitation light and collects fluorescence, yielding an aggregate activity-related signal rather than individually resolved spikes. (pmc.ncbi.nlm.nih.gov) In 2016, Christina K. Kim, Samuel J. Yang, and collaborators introduced frame-projected independent-fiber photometry, which images multiple fiber ends to measure signals from several brain regions or pathways simultaneously, including two-color measurements. Such recordings characterize timing and relationships among signals; causal tests require distinct interventions that alter activity, even when recording and perturbation are incorporated into the same apparatus. (nature.com)

Scientific collaboration, teaching, and dissemination

Deisseroth’s laboratory at Stanford University brings together engineering, molecular biology, systems neuroscience, and clinical psychiatry. Its institutional affiliations span Bioengineering, Psychiatry and Behavioral Sciences, Stanford Bio-X, and the Howard Hughes Medical Institute. The laboratory’s documented research program combines optical instrumentation, electrophysiology, computational analysis, molecular methods, and behavioral experiments in freely moving mammals. These approaches serve complementary purposes: developing tools to manipulate defined neural populations, mapping their anatomical and molecular properties, and measuring circuit activity during behavior. Its clinical connection is reflected in research questions concerning pathological circuit dynamics and neuropsychiatric symptoms, alongside investigations of normal neural function. (biox.stanford.edu)

His educational responsibilities extended beyond graduate research supervision. Stanford Psychiatry’s 2017 departmental update credited him with developing and launching the university’s undergraduate bioengineering degree and identified him, during the period covered by that account, as Director of Undergraduate Education in Bioengineering. It also recorded annual teaching in medical physiology and optics. These were distinct components of his work: undergraduate program development, educational administration, and subject teaching across biological function and physical measurement. Research mentoring provided another route into interdisciplinary training. For example, Stanford Bio-X’s account of 2017 undergraduate fellow Daniel Tang describes a project in Deisseroth’s group combining activity-dependent neuronal labeling, molecular biology, optics, imaging, and CLARITY to investigate stimulus-responsive neural populations. (med.stanford.edu)

Dissemination included practical instruction as well as publication. A February 12, 2015, National Institutes of Health account reported that Deisseroth offered free, three-day workshops on optogenetics and CLARITY throughout the year, supported by a research supplement from the National Institute of Neurological Disorders and Stroke. The laboratory’s CLARITY resource program also assembled short- and extended-workshop information, methodological reviews, supplementary experimental instructions, imaging videos, and downloadable mouse-brain image stacks. These resources gave researchers access not only to descriptions of the technique but also to procedural documentation and examples of its imaging output. (braininitiative.nih.gov)

Methodological publications supplied more detailed experimental guidance. In 2014, Raju Tomer, Li Ye, Brian Hsueh, and Deisseroth published “Advanced CLARITY for rapid and high-resolution imaging of intact tissues” in Nature Protocols, volume 9, pages 1682–1697. The laboratory’s resource page connects that article with high-resolution figures, supplementary videos, and CLARITY-optimized light-sheet microscopy resources; it also groups the original 2013 collaborative paper with subsequent applications and reviews. This publication-and-resource structure supported transfer of tissue preparation and imaging methods between laboratories, rather than limiting dissemination to reports of biological findings. (dlab.stanford.edu)

Deisseroth also contributed to collective planning for neuroscience technology development. He was one of 19 coauthors, including Lyric Jorgenson, William Newsome, and Cornelia Bargmann, of the 2015 paper “The BRAIN Initiative: developing technology to catalyse neuroscience discovery,” published in Philosophical Transactions of the Royal Society B. The article summarized the NIH working group’s scientific vision, emphasizing cell-type identification, circuit mapping, large-scale activity recording, causal manipulation, and integration with theory and data analysis. Its core principles included interdisciplinary collaboration, shared data platforms, and iterative validation of new methods through interaction between tool developers and experimental users. His documented contribution was participation in the working group and coauthorship of this collective agenda, not sole direction of the initiative. (pubmed.ncbi.nlm.nih.gov)

Literary nonfiction and public communication

Deisseroth’s first book, Projections: A Story of Human Emotions, was published by Random House on June 15, 2021. His laboratory biography identifies it as literary nonfiction, rather than a technical research monograph. Written for a general readership, it combines psychiatric encounters, personal experience, historical imagination, and explanations of neuroscience. Its development extended over approximately two decades: in a June 2021 Stanford Medicine interview, Deisseroth recalled writing the chapter “First Break” during his psychiatry residency, shortly after the September 11, 2001 attacks, before establishing his laboratory. Other material reaches forward to the coronavirus pandemic. (dlab.stanford.edu)

The book uses clinical narratives to examine questions about the biological origins of emotion: how hunger and thirst relate to conscious motivation, how the capacity for joy can be disrupted, and why social attachment is central to human experience. Accounts of neural circuitry appear alongside descriptions of emotional suffering, connecting bodily processes with the experiences through which people understand themselves and others. Rather than organizing these subjects as a catalogue of diagnoses, Projections moves between individual encounters and broader questions about shared human capacities. The publisher describes this approach as an exploration of what mental illness can reveal about the mind and about human beings as social organisms. (penguinrandomhouse.com)

The clinical material also has a literary status that distinguishes it from published case reports or controlled experiments. Stanford Medicine’s interview describes the book as incorporating fictionalized stories and historical imagination; its narratives should therefore not be read as verbatim clinical documentation. Deisseroth explained there that a single perspective was insufficient for the understanding he sought, and that literature, medicine, science, and human history supplied different kinds of insight. This distinction matters for the book’s movement between observation and explanation: a narrated encounter can frame a question about emotion without itself establishing a neural mechanism or a causal relationship. The book presents scientific knowledge within a wider interpretive narrative, rather than treating every narrative connection as an experimentally demonstrated finding. (med.stanford.edu)

Deisseroth also communicated neuroscience through public lectures. On October 20, 2021, he delivered the Lasker Public Lecture, “Light-Activated Microbial Molecules,” co-hosted by the Lasker Foundation and the Secret Science Club, a nonprofit connecting researchers with public audiences. The lecture traced the progression from light-sensitive microbial molecules to optogenetics experiments in freely moving animals, explaining how the method helps investigate the roles of particular neuronal classes and individual neurons within brain circuits. Its scope included basic science and potential clinical applications, rather than presenting those possibilities as established treatments. The foundation subsequently made a recording available, extending access beyond the live event; its stated purpose for the lecture series is dialogue between scientists and interested members of the public. (laskerfoundation.org)

Awards and professional recognition

Deisseroth was elected to the U.S. National Academy of Medicine in 2010, when it was known as the Institute of Medicine, to the National Academy of Sciences in 2012, and to the National Academy of Engineering in 2019. The contemporary announcement of his Institute of Medicine election identified both his clinical work in psychiatry and his development of optogenetics, emphasizing the method’s ability to connect experimentally controlled neural activity with behavior. These academy memberships are distinct from the research prizes subsequently awarded for particular scientific achievements. (med.stanford.edu)

In 2013, Deisseroth shared the Brain Prize, formally the Grete Lundbeck European Brain Research Prize, with Ernst Bamberg, Edward Boyden, Peter Hegemann, Gero Miesenböck, and Georg Nagel. The six researchers were recognized for the invention and refinement of optogenetics, and shared an award of €1 million. The recipient group encompassed research on microbial light-sensitive proteins and the development of methods for controlling neural activity with light; the award therefore recognized contributions from several laboratories rather than attributing the technique to a single inventor. The Massachusetts Institute of Technology’s announcement specifically described Boyden’s collaboration with Deisseroth at Stanford University as building on earlier discoveries by the four European recipients. (oxfordmartin.ox.ac.uk)

The 2018 Kyoto Prize in Advanced Technology recognized Deisseroth in the field of biotechnology and medical technology. Its stated grounds were his discovery of optogenetics and development of causal systems neuroscience. The Inamori Foundation’s citation emphasized the capacity to activate or inhibit selected neurons on a millisecond timescale and thereby test how particular patterns of neural activity contribute to function. It distinguished these interventions from observations that establish correlations alone, while also noting his dissemination of experimental resources, protocols, and training. (kyotoprize.org)

In 2021, Deisseroth received the Albert Lasker Basic Medical Research Award jointly with Peter Hegemann and Dieter Oesterhelt. The award recognized the discovery of light-sensitive microbial proteins capable of activating or silencing individual brain cells and their use in developing optogenetics. Its account differentiated the recipients’ contributions: Oesterhelt’s investigations established light-driven ion transport by microbial proteins; Hegemann’s research helped identify the light-gated channels of single-celled algae; and Deisseroth’s work brought microbial proteins into methods for manipulating neuronal activity. The recognition thus connected fundamental microbial biochemistry with experimental tools for neuroscience, rather than honoring a demonstrated clinical treatment. (laskerfoundation.org)

Deisseroth and Gero Miesenböck shared the 2023 Japan Prize in Life Sciences for developing methods that use genetically targeted light-sensitive membrane proteins to investigate neural-circuit function. The Japan Prize Foundation distinguished Miesenböck’s development of genetically specified optical control from Deisseroth’s subsequent use of microbial light-activated proteins to achieve high temporal precision. Its citation highlighted the resulting ability to test causal relationships between the activity of selected neurons and functions measured in an organism. (japanprize.jp)

On October 5, 2026, Deisseroth, Peter Hegemann, and Georg Nagel were announced as the joint recipients of the 2026 Nobel Prize in Physiology or Medicine for discoveries concerning light-gated ion channels and optogenetics. This recipient group differed from the 2021 Lasker group: Hegemann and Deisseroth received both awards, whereas Nagel shared the Nobel and Oesterhelt shared the Lasker. The October announcement established the Nobel selection; it was separate from the subsequent formal presentation of the prizes at the December 10 ceremony. (apnews.com)

References

1. Karl Deisseroth | Kyoto Prizekyotoprize.org
2. The 2018 Kyoto Prize | Kyoto Prizekyotoprize.org
3. cvweb.stanford.edu
4. Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neuronsnature.com
5. letters to natureweb.stanford.edu
6. Karl Deisseroth's Profile | Stanford Profilesprofiles.stanford.edu
7. Karl Deisseroth | Bioengineeringbioengineering.stanford.edu
8. Karl Deisseroth | HHMI Investigator | 2014-Presenthhmi.org
9. Karl Deisseroth Awarded Else Kröner Fresenius Prize | HHMIhhmi.org
10. Rhodopsin-like Protein from the Purple Membrane of Halobacterium halobiumnature.com
11. Light-sensitive microbial proteins and optogeneticslaskerfoundation.org
12. Channelrhodopsin-2, a directly light-gated cation-selective membrane channelpubmed.ncbi.nlm.nih.gov
13. Millisecond-timescale, genetically targeted optical control of neural activitypubmed.ncbi.nlm.nih.gov
14. Millisecond-timescale, genetically targeted optical control of neural activityweb.stanford.edu
15. An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technologypubmed.ncbi.nlm.nih.gov
16. An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technologyweb.stanford.edu
17. Neural substrates of awakening probed with optogenetic control of hypocretin neuronspubmed.ncbi.nlm.nih.gov
18. Neural substrates of awakening probed with optogenetic control of hypocretin neuronspmc.ncbi.nlm.nih.gov
19. The Microbial Opsin Family of Optogenetic Toolspmc.ncbi.nlm.nih.gov
20. Crystal structure of the channelrhodopsin light-gated cation channelnature.com
21. Red-shifted optogenetic excitation: a tool for fast neural control derived from Volvox carteripubmed.ncbi.nlm.nih.gov
22. Color-tuned Channelrhodopsins for Multiwavelength Optogeneticspmc.ncbi.nlm.nih.gov
23. Crystal structure of the natural anion-conducting channelrhodopsin GtACR1nature.com
24. Crystal structure of the natural anion-conducting channelrhodopsin GtACR1pmc.ncbi.nlm.nih.gov
25. Natural neural projection dynamics underlying social behaviorpmc.ncbi.nlm.nih.gov
26. Natural Neural Projection Dynamics Underlying Social Behaviorescholarship.org
27. Nucleus accumbens D2R cells signal prior outcomes and control risky decision-makingpmc.ncbi.nlm.nih.gov
28. Thirst regulates motivated behavior through modulation of brainwide neural population dynamicspmc.ncbi.nlm.nih.gov
29. Cortical layer–specific critical dynamics triggering perceptionpmc.ncbi.nlm.nih.gov
30. Researchers pinpoint brain circuitry underlying dissociative experiencesmed.stanford.edu
31. Deep posteromedial cortical rhythm in dissociationnature.com
32. Deep posteromedial cortical rhythm in dissociationweb.stanford.edu
33. Structural and molecular interrogation of intact biological systemsnature.com
34. Structural and molecular interrogation of intact biological systems - PMCpmc.ncbi.nlm.nih.gov
35. Pathways to clinical CLARITY: volumetric analysis of irregular, soft, and heterogeneous tissues in development and disease - PMCpmc.ncbi.nlm.nih.gov
36. Pathways to clinical CLARITY: volumetric analysis of irregular, soft, and heterogeneous tissues in development and diseasenature.com
37. Three-dimensional intact-tissue sequencing of single-cell transcriptional statesrnajc.ucsf.edu
38. Cell-type-specific population dynamics of diverse reward computationspmc.ncbi.nlm.nih.gov
39. Cell-type-specific population dynamics of diverse reward computationsescholarship.org
40. Simultaneous fast measurement of circuit dynamics at multiple sites across the mammalian brainnature.com
41. Clarity | Deisseroth Labdlab.stanford.edu
42. The BRAIN Initiative: developing technology to catalyse neuroscience discovery - PubMedpubmed.ncbi.nlm.nih.gov
43. The BRAIN Initiative: developing technology to catalyse neuroscience discoveryweb.stanford.edu
44. Karl Deisserothdlab.stanford.edu
45. Projections by Karl Deisserothpenguinrandomhouse.com
46. Neuroscientist's book traverses the extremes of human behaviormed.stanford.edu
47. Karl Deisseroth: Light-Activated Microbial Moleculeslaskerfoundation.org
48. Institute of Medicine awards membership to Deisseroth, Gallimed.stanford.edu
49. Karl Deisseroth | Stanford Medicinemed.stanford.edu
50. Brain Prize for Optogenetics | Oxford Martin Schooloxfordmartin.ox.ac.uk
51. Boyden to share prestigious brain prize | MIT Newsnews.mit.edu
52. The Japan Prize Foundationjapanprize.jp
53. EU-funded researcher Peter Hegemann wins 2026 Nobel Prize in Physiology or Medicineresearch-and-innovation.ec.europa.eu